News tagged with adverse reactions

ER visits tied to ambien on the rise

(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.

May 01, 2013
popularity not rated yet | comments 0

Lymphoseek approved to help locate lymph nodes

(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.

Mar 13, 2013
popularity not rated yet | comments 0

New report offers assurance, future research on kids' shots

New parents quickly learn that their kids have years of vaccinations ahead of them. The vast majority of parents keep up with the schedule but some parents diverge from the recommended timeline, and a small minority object ...

Jan 18, 2013
popularity not rated yet | comments 0

Octaplas approved for blood-clotting disorders

(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.

Jan 17, 2013
popularity not rated yet | comments 0

Signifor approved for Cushing's disease

(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.

Dec 17, 2012
popularity not rated yet | comments 0

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Nov 07, 2012
popularity not rated yet | comments 0